Systematic Literature Review on Buprenorphine/naloxone Use in Outpatient Opioid Dependence Treatment

被引:0
|
作者
Main, Fiona [1 ]
Kelly, Len
机构
[1] Northern Ontario Sch Med, Family Med, Sudbury, ON, Canada
关键词
addiction; opioid substitution therapy; buprenorphine/naloxone; outpatient;
D O I
暂无
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Objective: Summarize the literature on buprenorphine/ naloxone for outpatient treatment of opioid dependence disorder. Methods: a literature of EMBASE and Medline 2000-2014 using the terms "naloxone + buprenorphine" and "opioid-related disorders". Results: Over two hundred articles were retrieved. Seventeen studies were ultimately selected and reviewed for study quality, using Downs and Black's 1998 checklist, the Canadian Task Force on Preventive Health Care levels of evidence and study outcome analysis. Conclusion: Buprenorphine/naloxone appears to be a safe, effective treatment modality for treatment of opioid dependence. As a recently introduced medication in North America, clinicians are slow to fully embrace it use. It provides an opportunity to more widely provide opioid substitution therapy in primary care settings.
引用
收藏
页码:12 / 18
页数:7
相关论文
共 50 条
  • [31] Home induction and outpatient treatment of kratom use disorder with buprenorphine-naloxone: A case report in a young adult
    Schmuhl, Kelsey K.
    Gardner, Spencer M.
    Cottrill, Casey B.
    Bonny, Andrea E.
    SUBSTANCE ABUSE, 2020, 41 (03) : 311 - 314
  • [32] Evaluating outcomes of a clinical pharmacist medication management program in a multidisciplinary practice for outpatient buprenorphine treatment of opioid use disorder
    Mattle, Anna G.
    Aladeen, Traci
    Blondell, Richard D.
    Capote, Horacio
    Rainka, Michelle
    JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, 2021, 4 (04): : 424 - 434
  • [33] The use of auricular acupuncture in opioid use disorder: A systematic literature review
    Baker, Tanya E.
    Chang, Grace
    AMERICAN JOURNAL ON ADDICTIONS, 2016, 25 (08) : 592 - 602
  • [34] Buprenorphine Treatment for Opioid Use Disorder: An Overview
    Shulman, Matisyahu
    Wai, Jonathan M.
    Nunes, Edward V.
    CNS DRUGS, 2019, 33 (06) : 567 - 580
  • [35] Suboxone® (Buprenorphine/Naloxone) as an Agonist Opioid Treatment in Spain: A Budgetary Impact Analysis
    Martinez-Raga, Jose
    Gonzalez Saiz, Francisco
    Pascual, Cesar
    Casado, Miguel A.
    Sabater Torres, Francisco J.
    EUROPEAN ADDICTION RESEARCH, 2010, 16 (01) : 31 - 42
  • [36] Sexual dysfunction in patients with opioid use disorder: A comparison between naltrexone implant and buprenorphine/naloxone maintenance treatment
    Caliskan, Ali Metehan
    Yildiz, Mustafa Cagri
    HEROIN ADDICTION AND RELATED CLINICAL PROBLEMS, 2022, 24 (01) : 47 - 52
  • [37] Treatment Experiences for Patients Receiving Buprenorphine/Naloxone for Opioid Use Disorder: A Qualitative Study of Patients' Perceptions and Attitudes
    Young, Gary J.
    Hasan, Md Mahmudul
    Young, Leonard D.
    Noor-E-Alam, Md.
    SUBSTANCE USE & MISUSE, 2023, 58 (04) : 512 - 519
  • [38] Opioid Addicted Buprenorphine Injectors: Drug Use During and After 12-Weeks of Buprenorphine-Naloxone or Methadone in the Republic of Georgia
    Piralishvili, Gvantsa
    Otiashvili, David
    Sikharulidze, Zura
    Kamkamidze, George
    Poole, Sabrina
    Woody, George E.
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2015, 50 : 32 - 37
  • [39] Variants of opioid genes and response to treatment of opioid use disorder with buprenorphine-naloxone versus extended-release naltrexone in Caucasians
    Randesi, Matthew
    Rotrosen, John
    Nunes, Edward, V
    Lee, Joshua D.
    Novo, Patricia
    Levran, Orna
    Ott, Jurg
    Pavlicova, Martina
    Scodes, Jennifer
    Kreek, Mary Jeanne
    AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE, 2020, 46 (06) : 761 - 768
  • [40] Buprenorphine: Therapeutical use in opioid-dependence, depression and schizophrenia
    Paetzold, W
    Schneider, U
    Seifert, J
    Eronat, V
    Emrich, HM
    NERVENHEILKUNDE, 2000, 19 (03) : 143 - 150